Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Gastroenterology. 2010 Dec 1;140(3):840–849.e1. doi: 10.1053/j.gastro.2010.11.050

Figure 1.

Figure 1

Figure 1

Figure 1

Cumulative incidence of HCC; (A) by treatment assignment: peginterferon vs. control; (B) by treatment assignment and fibrosis strata (Ishak fibrosis stage 5 or 6 [cirrhosis] vs. Ishak 3 or 4 [fibrosis] at baseline); and (C) by treatment assignment and fibrosis strata for patients who were still at risk 3.75 years after randomization.